Seeing Is Believing
Currently, out of the existing stock ratings of Joseph Munda - 14 which are a Buy (87.5%), 2 which are a Hold (12.5%)
Analyst Joseph Munda works at FIRST ANALYSIS and is covering Healthcare, Industrials sectors with 37 price targets and ratings displayed on 5 stocks.
Joseph Munda's average stock forecast success ratio is 89.33% with an average time for price targets to be met of 540.4 days.
Most recent stock forecast was given on NEO, NeoGenomics at 28-Feb-2020.
Analyst best performing recommendations are on NEO (NEOGENOMICS).
The best stock recommendation documented was for NEO (NEOGENOMICS) at 10/24/2018. The price target of $18 was fulfilled within 7 days with a profit of $3.59 (24.91%) receiving and performance score of 35.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
24
$5.31 (28.41%)
1 months 19 days ago
7/9 (77.78%)
$3.56 (10.76%)
104
Hold
35
$16.37 (87.87%)
55
1 years 6 months 23 days ago
0/2 (0%)
$12.77 (40.00%)
Hold
46
$27.31 (146.12%)
46
1 years 10 months 15 days ago
0/2 (0%)
$5.38 (13.25%)
Buy
65
$46.31 (247.78%)
54
3 years 8 months 23 days ago
4/5 (80%)
$5.19 (12.48%)
25
What Year was the first public recommendation made by Joseph Munda?